Simon’s options for Capital Shopping takeover dwindling
Simon Property Group Inc. may be running out of options in its quest to take over Capital Shopping Centres Group Plc and become the largest mall owner in the United Kingdom.
Simon Property Group Inc. may be running out of options in its quest to take over Capital Shopping Centres Group Plc and become the largest mall owner in the United Kingdom.
Capital Shopping Centres Group Plc, Britain’s biggest shopping-mall owner, rejected a financing plan that would have given potential suitor Simon Property Group Inc. a larger stake in the company.
Duke, the Indiana Utility Consumer Counselor and other groups will renegotiate the terms of a plan to boost rates to raise $530 million for Duke’s Edwardsport plant, the Charlotte, N.C.-based company
Twenty for-profit colleges—led by Carmel-based ITT Educational Services—reaped $521 million in U.S. taxpayer funds in 2010 by recruiting armed-services members and veterans through misleading marketing, according to a Congressional report released Thursday.
The company expects to employ more than 800 workers at the plant within five years, producing filters and generators for motor vehicles.
Carmel-based CNO Financial Group Inc., the insurer formerly known as Conseco Inc., plans to sell $300 million of seven-year senior-secured notes, according to a company statement.
Indianapolis-based Simon Property Group Inc. will end its interest in buying Capital Shopping Centres Group Plc if the U.K. company doesn’t provide information necessary to evaluate a bid.
A unit of Bayer AG, Europe’s largest drug and chemical maker, is suing Indianapolis-based Dow AgroSciences LLC in federal court in Delaware alleging infringement of a U.S. patent for herbicide-resistant crops.
Indianapolis-based Republic Airways Holdings Inc. and its Frontier Airlines unit filed a trademark-infringement case against the operator of a website offering gift cards as consumer incentives.
Rick Scott of Florida will get another chance next month to derail the law President Obama signed in March when he and 21 other Republican governors-elect are sworn in just as states begin implementing details of the legislation the candidates campaigned against.
Shares of Capital Shopping Centres Group Plc, Britain’s biggest mall owner, rose the most since the company went public in 1992 after saying Indianapolis-based Simon Property Group Inc. may offer more than $3.6 billion in cash for the company.
U.S. health insurers, including WellPoint Inc., can include the cost of federal taxes in determining whether they spend enough on patient care, the U.S. Health and Human Services Department said Tuesday.
An expected push to refresh the oldest North American commercial trucking fleet in at least 31 years should boost sales at partsmakers like Columbus-based Cummins Inc.
Republican governors meeting in San Diego said Thursday their statehouse victories in the Midwest leave the party well positioned for 2012 in the battlefield that often determines the presidency.
Indianapolis-based Simon Property Group Inc., the U.S. shopping-mall owner that paid $2.3 billion this year for an outlet-center business, has plenty of capital for more purchases, CEO David Simon said Tuesday.
Pharmaceutical firms led by Eli Lilly are trying to eliminate a government panel aimed at controlling Medicare spending seven months after they supported the health-care overhaul that created it.
Indiana among those rolling out new, less-risky 529 plans to attract savers wary of losing money in the stock market.
The U.S. Federal Trade Commission said it is requiring Indianapolis-based Simon Property Group Inc., the largest U.S. mall owner, to sell outlets in a settlement related to the $2.3M purchase of Prime Outlets Acquisition Co.
Merck & Co. is betting it can succeed where Pfizer Inc. failed, with a new type of drug to combat heart disease by raising good cholesterol levels. Indianapolis-based Eli Lilly and Co. is testing a similar pill.
The Food and Drug Administration has cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back conditions, which could mean another $500 million in annual sales for Lilly, an analyst estimates.